1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Small Interfering RNA (siRNA) Therapeutics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Small Interfering RNA (siRNA) Therapeutics Market Revenue and Volume Forecast, by Application
8.1.1. Cancer
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Neurological Disorders
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Cardiovascular Diseases
8.1.3.1. Market Revenue and Volume Forecast
8.1.1. Ophthalmic Diseases
8.1.1.1. Market Revenue and Volume Forecast
8.1.1. Infectious Diseases
8.1.1.1. Market Revenue and Volume Forecast
8.1.1. Other Therapeutic Applications
8.1.1.1. Market Revenue and Volume Forecast
9.1. Small Interfering RNA (siRNA) Therapeutics Market Revenue and Volume Forecast, by Delivery System
9.1.1. Liposomes
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Polymers
9.1.2.1. Market Revenue and Volume Forecast
9.1.3. Lipid Nanoparticles
9.1.3.1. Market Revenue and Volume Forecast
9.1.4. Viral Vectors
9.1.4.1. Market Revenue and Volume Forecast
9.1.5. Other Delivery Systems
9.1.5.1. Market Revenue and Volume Forecast
10.1. Small Interfering RNA (siRNA) Therapeutics Market Revenue and Volume Forecast, by Synthetic Route
10.1.1. Chemical Synthesis
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Biotechnology
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. Other Synthetic Routes
10.1.3.1. Market Revenue and Volume Forecast
11.1. Small Interfering RNA (siRNA) Therapeutics Market Revenue and Volume Forecast, by Mechanism of Action
11.1.1. Gene Editing
11.1.1.1. Market Revenue and Volume Forecast
11.1.2. Gene Silencing
11.1.2.1. Market Revenue and Volume Forecast
11.1.3. MicroRNA Mimics
11.1.3.1. Market Revenue and Volume Forecast
11.1.4. Others
11.1.4.1. Market Revenue and Volume Forecast
11.1.5. siRNA-mediated mRNA decay)
11.1.5.1. Market Revenue and Volume Forecast
12.1. North America
12.1.1. Market Revenue and Volume Forecast, by Application
12.1.2. Market Revenue and Volume Forecast, by Delivery System
12.1.3. Market Revenue and Volume Forecast, by Synthetic Route
12.1.4. Market Revenue and Volume Forecast, by Mechanism of Action
12.1.5. U.S.
12.1.5.1. Market Revenue and Volume Forecast, by Application
12.1.5.2. Market Revenue and Volume Forecast, by Delivery System
12.1.5.3. Market Revenue and Volume Forecast, by Synthetic Route
12.1.5.4. Market Revenue and Volume Forecast, by Mechanism of Action
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Volume Forecast, by Application
12.1.6.2. Market Revenue and Volume Forecast, by Delivery System
12.1.6.3. Market Revenue and Volume Forecast, by Synthetic Route
12.1.6.4. Market Revenue and Volume Forecast, by Mechanism of Action
12.2. Europe
12.2.1. Market Revenue and Volume Forecast, by Application
12.2.2. Market Revenue and Volume Forecast, by Delivery System
12.2.3. Market Revenue and Volume Forecast, by Synthetic Route
12.2.4. Market Revenue and Volume Forecast, by Mechanism of Action
12.2.5. UK
12.2.5.1. Market Revenue and Volume Forecast, by Application
12.2.5.2. Market Revenue and Volume Forecast, by Delivery System
12.2.5.3. Market Revenue and Volume Forecast, by Synthetic Route
12.2.5.4. Market Revenue and Volume Forecast, by Mechanism of Action
12.2.6. Germany
12.2.6.1. Market Revenue and Volume Forecast, by Application
12.2.6.2. Market Revenue and Volume Forecast, by Delivery System
12.2.6.3. Market Revenue and Volume Forecast, by Synthetic Route
12.2.6.4. Market Revenue and Volume Forecast, by Mechanism of Action
12.2.7. France
12.2.7.1. Market Revenue and Volume Forecast, by Application
12.2.7.2. Market Revenue and Volume Forecast, by Delivery System
12.2.7.3. Market Revenue and Volume Forecast, by Synthetic Route
12.2.7.4. Market Revenue and Volume Forecast, by Mechanism of Action
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Volume Forecast, by Application
12.2.8.2. Market Revenue and Volume Forecast, by Delivery System
12.2.8.3. Market Revenue and Volume Forecast, by Synthetic Route
12.2.8.4. Market Revenue and Volume Forecast, by Mechanism of Action
12.3. APAC
12.3.1. Market Revenue and Volume Forecast, by Application
12.3.2. Market Revenue and Volume Forecast, by Delivery System
12.3.3. Market Revenue and Volume Forecast, by Synthetic Route
12.3.4. Market Revenue and Volume Forecast, by Mechanism of Action
12.3.5. India
12.3.5.1. Market Revenue and Volume Forecast, by Application
12.3.5.2. Market Revenue and Volume Forecast, by Delivery System
12.3.5.3. Market Revenue and Volume Forecast, by Synthetic Route
12.3.5.4. Market Revenue and Volume Forecast, by Mechanism of Action
12.3.6. China
12.3.6.1. Market Revenue and Volume Forecast, by Application
12.3.6.2. Market Revenue and Volume Forecast, by Delivery System
12.3.6.3. Market Revenue and Volume Forecast, by Synthetic Route
12.3.6.4. Market Revenue and Volume Forecast, by Mechanism of Action
12.3.7. Japan
12.3.7.1. Market Revenue and Volume Forecast, by Application
12.3.7.2. Market Revenue and Volume Forecast, by Delivery System
12.3.7.3. Market Revenue and Volume Forecast, by Synthetic Route
12.3.7.4. Market Revenue and Volume Forecast, by Mechanism of Action
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Volume Forecast, by Application
12.3.8.2. Market Revenue and Volume Forecast, by Delivery System
12.3.8.3. Market Revenue and Volume Forecast, by Synthetic Route
12.3.8.4. Market Revenue and Volume Forecast, by Mechanism of Action
12.4. MEA
12.4.1. Market Revenue and Volume Forecast, by Application
12.4.2. Market Revenue and Volume Forecast, by Delivery System
12.4.3. Market Revenue and Volume Forecast, by Synthetic Route
12.4.4. Market Revenue and Volume Forecast, by Mechanism of Action
12.4.5. GCC
12.4.5.1. Market Revenue and Volume Forecast, by Application
12.4.5.2. Market Revenue and Volume Forecast, by Delivery System
12.4.5.3. Market Revenue and Volume Forecast, by Synthetic Route
12.4.5.4. Market Revenue and Volume Forecast, by Mechanism of Action
12.4.6. North Africa
12.4.6.1. Market Revenue and Volume Forecast, by Application
12.4.6.2. Market Revenue and Volume Forecast, by Delivery System
12.4.6.3. Market Revenue and Volume Forecast, by Synthetic Route
12.4.6.4. Market Revenue and Volume Forecast, by Mechanism of Action
12.4.7. South Africa
12.4.7.1. Market Revenue and Volume Forecast, by Application
12.4.7.2. Market Revenue and Volume Forecast, by Delivery System
12.4.7.3. Market Revenue and Volume Forecast, by Synthetic Route
12.4.7.4. Market Revenue and Volume Forecast, by Mechanism of Action
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Volume Forecast, by Application
12.4.8.2. Market Revenue and Volume Forecast, by Delivery System
12.4.8.3. Market Revenue and Volume Forecast, by Synthetic Route
12.4.8.4. Market Revenue and Volume Forecast, by Mechanism of Action
12.5. Latin America
12.5.1. Market Revenue and Volume Forecast, by Application
12.5.2. Market Revenue and Volume Forecast, by Delivery System
12.5.3. Market Revenue and Volume Forecast, by Synthetic Route
12.5.4. Market Revenue and Volume Forecast, by Mechanism of Action
12.5.5. Brazil
12.5.5.1. Market Revenue and Volume Forecast, by Application
12.5.5.2. Market Revenue and Volume Forecast, by Delivery System
12.5.5.3. Market Revenue and Volume Forecast, by Synthetic Route
12.5.5.4. Market Revenue and Volume Forecast, by Mechanism of Action
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Volume Forecast, by Application
12.5.6.2. Market Revenue and Volume Forecast, by Delivery System
12.5.6.3. Market Revenue and Volume Forecast, by Synthetic Route
12.5.6.4. Market Revenue and Volume Forecast, by Mechanism of Action
13.1. Silence Therapeutics
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Silenseed Ltd
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Sylentis, S.A.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Quark Pharmaceuticals
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Sanofi Genzyme
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Dicerna Pharmaceuticals
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Novo Nordisk
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Novartis
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. GSK
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Aro Biotherapeutics
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
15.1. About Us
15.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
